Renal cell carcinoma risk factors: Difference between revisions

Jump to navigation Jump to search
(Created page with "{{CMG}} {{Renal cell carcinoma}} ==Overview== ==Risk factors== A history of smoking greatly increases the risk for developing renal cell carcinoma. ===Genetic risk factors...")
 
No edit summary
 
(20 intermediate revisions by 7 users not shown)
Line 1: Line 1:
{{CMG}}
__NOTOC__
{{Renal cell carcinoma}}
{{Renal cell carcinoma}}
{{CMG}} {{AE}} {{F.K}}


==Overview==
==Overview==
Common [[risk factors]] for the development of renal cell carcinoma include cigarette smoking, [[obesity]], [[hypertension]], end-stage [[renal failure]], acquired cystic renal disease, [[acetaminophen]] and analgesic drug use, [[asbestos]] or trichloroethylene exposure, [[tuberous sclerosis]], [[Von Hippel Lindau syndrome|Von-Hippel Lindau disease]], hereditary [[paraganglioma]], [[leiomyomatosis]], and [[Birt-Hogg-Dube syndrome|birt-hogg-dube syndrome]].


==Risk factors==
==Risk factors==
A history of smoking greatly increases the risk for developing renal cell carcinoma.  
Common risk factors in the development of renal cell carcinoma include:<ref name="pmid15523697">{{cite journal| author=Hunt JD, van der Hel OL, McMillan GP, Boffetta P, Brennan P| title=Renal cell carcinoma in relation to cigarette smoking: meta-analysis of 24 studies. | journal=Int J Cancer | year= 2005 | volume= 114 | issue= 1 | pages= 101-8 | pmid=15523697 | doi=10.1002/ijc.20618 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15523697  }} </ref><ref name="pmid9610793">{{cite journal| author=Yuan JM, Castelao JE, Gago-Dominguez M, Yu MC, Ross RK| title=Tobacco use in relation to renal cell carcinoma. | journal=Cancer Epidemiol Biomarkers Prev | year= 1998 | volume= 7 | issue= 5 | pages= 429-33 | pmid=9610793 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9610793  }} </ref><ref name="pmid15583369">{{cite journal| author=Bjørge T, Tretli S, Engeland A| title=Relation of height and body mass index to renal cell carcinoma in two million Norwegian men and women. | journal=Am J Epidemiol | year= 2004 | volume= 160 | issue= 12 | pages= 1168-76 | pmid=15583369 | doi=10.1093/aje/ | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15583369  }} </ref><ref name="pmid15583368">{{cite journal| author=van Dijk BA, Schouten LJ, Kiemeney LA, Goldbohm RA, van den Brandt PA| title=Relation of height, body mass, energy intake, and physical activity to risk of renal cell carcinoma: results from the Netherlands Cohort Study. | journal=Am J Epidemiol | year= 2004 | volume= 160 | issue= 12 | pages= 1159-67 | pmid=15583368 | doi=10.1093/aje/ | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15583368  }} </ref><ref name="pmid12653256">{{cite journal| author=Ishikawa I, Saito Y, Asaka M, Tomosugi N, Yuri T, Watanabe M et al.| title=Twenty-year follow-up of acquired renal cystic disease. | journal=Clin Nephrol | year= 2003 | volume= 59 | issue= 3 | pages= 153-9 | pmid=12653256 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12653256  }} </ref><ref name="pmid17003820">{{cite journal| author=Rakowski SK, Winterkorn EB, Paul E, Steele DJ, Halpern EF, Thiele EA| title=Renal manifestations of tuberous sclerosis complex: Incidence, prognosis, and predictive factors. | journal=Kidney Int | year= 2006 | volume= 70 | issue= 10 | pages= 1777-82 | pmid=17003820 | doi=10.1038/sj.ki.5001853 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17003820  }} </ref><ref name="pmid7829242">{{cite journal| author=McCredie M, Pommer W, McLaughlin JK, Stewart JH, Lindblad P, Mandel JS et al.| title=International renal-cell cancer study. II. Analgesics. | journal=Int J Cancer | year= 1995 | volume= 60 | issue= 3 | pages= 345-9 | pmid=7829242 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7829242  }} </ref><ref name="pmid19269025">{{cite journal| author=Rini BI, Campbell SC, Escudier B| title=Renal cell carcinoma. | journal=Lancet | year= 2009 | volume= 373 | issue= 9669 | pages= 1119-32 | pmid=19269025 | doi=10.1016/S0140-6736(09)60229-4 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19269025  }} </ref>
 
* Active and passive cigarette smoking
===Genetic risk factors===
*[[Obesity]]
Some people may also have inherited an increased risk to develop renal cell carcinoma, and a family history of kidney cancer increases the risk. People with [[von Hippel-Lindau disease]], a hereditary disease that also affects the capillaries of the [[brain]], commonly also develop renal cell carcinoma.  
* [[Hypertension]]
 
* End-stage [[renal failure]]
====Autosomal dominant conditions====
* Acquired cystic renal disease
 
* [[Acetaminophen]] and analgesic drug use
*Occupational exposure
** [[Asbestos]]
**Trichloroethylene
**Cadmium
* [[Tuberous sclerosis]]
*[[Von Hippel Lindau syndrome|Von-Hippel Lindau syndrome]]
* [[Leiomyomatosis]]
* [[Birt-Hogg-Dube syndrome]]
* [[Birt-Hogg-Dube syndrome]]
* Hereditary [[leiomyomatosis]] and renal cell cancer
*Chronic [[hepatitis C]] infection
* Hereditary nonpolyposis [[colorectal cancer]]
* [[von Hippel-Lindau syndrome]]
 
====Autosomal recessive conditions====
 
* [[Fumarase deficiency]]


==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
[[Category:Kidney diseases]]
[[Category:Types of cancer]]
[[Category:Nephrology]]
[[Category:Mature chapter]]
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Medicine]]
[[Category:Nephrology]]
[[Category:Surgery]]

Latest revision as of 16:55, 9 October 2019

Renal cell carcinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Renal cell carcinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural history, Complications and Prognosis

Diagnosis

Staging

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Renal cell carcinoma risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Renal cell carcinoma risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Renal cell carcinoma risk factors

CDC on Renal cell carcinoma risk factors

Renal cell carcinoma risk factors in the news

Blogs on Renal cell carcinoma risk factors

Directions to Hospitals Treating Renal cell carcinoma

Risk calculators and risk factors for Renal cell carcinoma risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Farima Kahe M.D. [2]

Overview

Common risk factors for the development of renal cell carcinoma include cigarette smoking, obesity, hypertension, end-stage renal failure, acquired cystic renal disease, acetaminophen and analgesic drug use, asbestos or trichloroethylene exposure, tuberous sclerosis, Von-Hippel Lindau disease, hereditary paraganglioma, leiomyomatosis, and birt-hogg-dube syndrome.

Risk factors

Common risk factors in the development of renal cell carcinoma include:[1][2][3][4][5][6][7][8]

References

  1. Hunt JD, van der Hel OL, McMillan GP, Boffetta P, Brennan P (2005). "Renal cell carcinoma in relation to cigarette smoking: meta-analysis of 24 studies". Int J Cancer. 114 (1): 101–8. doi:10.1002/ijc.20618. PMID 15523697.
  2. Yuan JM, Castelao JE, Gago-Dominguez M, Yu MC, Ross RK (1998). "Tobacco use in relation to renal cell carcinoma". Cancer Epidemiol Biomarkers Prev. 7 (5): 429–33. PMID 9610793.
  3. Bjørge T, Tretli S, Engeland A (2004). "Relation of height and body mass index to renal cell carcinoma in two million Norwegian men and women". Am J Epidemiol. 160 (12): 1168–76. doi:10.1093/aje/. PMID 15583369.
  4. van Dijk BA, Schouten LJ, Kiemeney LA, Goldbohm RA, van den Brandt PA (2004). "Relation of height, body mass, energy intake, and physical activity to risk of renal cell carcinoma: results from the Netherlands Cohort Study". Am J Epidemiol. 160 (12): 1159–67. doi:10.1093/aje/. PMID 15583368.
  5. Ishikawa I, Saito Y, Asaka M, Tomosugi N, Yuri T, Watanabe M; et al. (2003). "Twenty-year follow-up of acquired renal cystic disease". Clin Nephrol. 59 (3): 153–9. PMID 12653256.
  6. Rakowski SK, Winterkorn EB, Paul E, Steele DJ, Halpern EF, Thiele EA (2006). "Renal manifestations of tuberous sclerosis complex: Incidence, prognosis, and predictive factors". Kidney Int. 70 (10): 1777–82. doi:10.1038/sj.ki.5001853. PMID 17003820.
  7. McCredie M, Pommer W, McLaughlin JK, Stewart JH, Lindblad P, Mandel JS; et al. (1995). "International renal-cell cancer study. II. Analgesics". Int J Cancer. 60 (3): 345–9. PMID 7829242.
  8. Rini BI, Campbell SC, Escudier B (2009). "Renal cell carcinoma". Lancet. 373 (9669): 1119–32. doi:10.1016/S0140-6736(09)60229-4. PMID 19269025.